https://www.indianpharmapost.com/zydus-receives-final-approval-from-usfda-for-triazolam-tablets-135232022-12-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/alniche-life-sciences-launches-guthealthawareness-campaign-135242022-12-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-grants-appeal-for-ardelyxs-xphozah-135252022-12-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/innocare-get-approval-of-tafasitamab-with-lenalidomide-for-the-treatment-of-refractory-diffuse-large-b-cell-lymphoma-in-hong-kong-135262022-12-31T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-accepts-for-review-the-biologics-license-application-for-pfizers-investigational-menabcwy-in-adolescents-135272022-12-31T00:00:00+05:30always0.9